Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer-Reference-Cited by-同舟云学术

Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer

Published:2022-09 Issue:6 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Esplin Edward D.¹^ORCID,Nielsen Sarah M.¹^ORCID,Bristow Sara L.¹^ORCID,Garber Judy E.²^ORCID,Hampel Heather³^ORCID,Rana Huma Q.²^ORCID,Samadder N. Jewel⁴⁵⁶^ORCID,Shore Neal D.⁷^ORCID,Nussbaum Robert L.¹^ORCID

Affiliation:

1. Invitae, San Francisco, CA

2. Dana Farber Cancer Institute, Boston, MA

3. Division of Clinical Cancer Genomics, Department of Medical Oncology & Therapeutic Research, City of Hope National Cancer Center, Duarte, CA

4. Center for Individualized Medicine, Mayo Clinic, Phoenix, AZ

5. Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Phoenix, AZ

6. Department of Clinical Genomics, Mayo Clinic, Phoenix, AZ

7. Carolina Urologic Research Center, Myrtle Beach, SC

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.21.00516

Reference89 articles.

1. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

2. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome

3. Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer

4. Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk

5. Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors;npj Precision Oncology;2024-09-05

2. Universal screening of colorectal tumors for lynch syndrome: a survey of patient experiences and opinions;Hereditary Cancer in Clinical Practice;2024-09-05

3. Prevention of Ovarian Cancer: Where are We Now and Where are We Going?;Current Oncology Reports;2024-08-08

4. Self-reported awareness of genetic testing, the impact of family history, and access to clinical trials for people diagnosed with ovarian cancer in Australia;Gynecologic Oncology Reports;2024-08

5. Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world;ESMO Open;2024-06